ArticleEuropean journal of hospital pharmacy : science and practice2023

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19.

Shaghayegh Mohsenian Naghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.